Role of Pioglitazone in Preventing Diabetes

• Status: Completed
• Trial end date: 2008-05-01
• Target enrollment: 0
• Participant gender: All

Summary

A three year prospective, double blinded, placebo controlled, randomized clinical trial in impaired glucose tolerance (IGT) subjects to study the effect of pioglitazone in preventing the conversion to Diabetes.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: M.V. Hospital for Diabetes
• Collaborator: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
• Treatments: Pioglitazone

Criteria

Inclusion Criteria:

• Both male and female

• Age 35 - 55 years

• No known history of diabetes

• Willing and available for a 3 years study

Exclusion Criteria:

• Pregnant women

• Subjects with major illness such as cancer, hepatic or cardiac diseases

• Transferable jobs